INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

82,081 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$779K
45.0K sh
Jan 7, 2026
Page 1766 of 2053
← PrevNext →
Jan 7, 2026
traded Jan 7, 2026
+0d
SEC Form 4

Evidence

4
FR
Fukushima RyanChief Operating Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$321K
5,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

3
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Option exercise · 10b5-1 plan
M—
3,808 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

2
HK
Holleran KevinDirector, President and CEO
HAYWHayward Holdings, Inc.
Option exercise · 10b5-1 plan
M$73K
52.4K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

1
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$103K
20.8K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

1
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$103K
20.8K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

1
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
20.8K sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

1
KS
Kazmaier Gerrit SPresident, Prod. and Tech.
WDAYWorkday, Inc.
Tax withholding · 10b5-1 plan
F$499K
2,427 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

1
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$53K
2,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

1
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$5,318
2,102 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

1
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
2,500 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Option exercise · 10b5-1 plan
M$23K
2,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Derivative conversion · 10b5-1 plan
C—
166.4K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Option exercise · 10b5-1 plan
M$44K
3,808 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
DS
Desmond SeanDirector, CEO & President
NCNOnCino, Inc.
Option exercise · 10b5-1 plan
M$37K
7,331 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
Armstrong BrianDirector, Chairman and CEO, 10% Owner
COINCoinbase Global, Inc.
Option exercise · 10b5-1 plan
M—
40.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Derivative conversion · 10b5-1 plan
C—
44.9K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Derivative conversion · 10b5-1 plan
C—
166.4K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Derivative conversion · 10b5-1 plan
C—
44.9K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
Armstrong BrianDirector, Chairman and CEO, 10% Owner
COINCoinbase Global, Inc.
Option exercise · 10b5-1 plan
M$748K
40.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
Xu TonyDirector, CHIEF EXECUTIVE OFFICER, 10% Owner
DASHDoorDash, Inc.
Option exercise · 10b5-1 plan
M—
16.7K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Option exercise · 10b5-1 plan
M—
2,178 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
Tenev VladimirDirector, Chief Executive Officer
HOODRobinhood Markets, Inc.
Derivative conversion · 10b5-1 plan
C—
375.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
HK
Holleran KevinDirector, President and CEO
HAYWHayward Holdings, Inc.
Option exercise · 10b5-1 plan
M—
52.4K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Option exercise · 10b5-1 plan
M—
2,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Option exercise · 10b5-1 plan
M$11K
2,178 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
60.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
DS
Desmond SeanDirector, CEO & President
NCNOnCino, Inc.
Option exercise · 10b5-1 plan
M—
7,331 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

0
Tenev VladimirDirector, Chief Executive Officer
HOODRobinhood Markets, Inc.
Derivative conversion · 10b5-1 plan
C—
375.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence